update

Almac: investment to ensure space, staff, larger US footprint

By Melissa Fassbender contact

- Last updated on GMT

Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities. (Image: iStock/RomoloTavani)
Almac Group has announced a $5.2m investment at its Durham, North Carolina facilities. (Image: iStock/RomoloTavani)

Related tags: Almac clinical services, Clinical trial, Pharmacology

Yesterday, Almac Group announced a $5.2m investment in its US-based operations, which its global VP of operations said will support customers “across the drug development lifecycle.”

"Across the Almac companies there is a need to ensure that we are continually investing in staff and facilities to maintain the excellent standards that our customers have come to expect of us​," Donna Christopher, Global VP Operations, Almac Clinical Services, told Outsourcing-Pharma.com, adding that the company's activities in NC continue to grow and as such, it is "seeking to meet that additional demand​."

As Christopher said, the central drive behind this growth is "further enhancing the offering we are able to make to our customers right across the drug development lifecycle​."

At the company's North Carolina-based facility, this means "focuses on supporting clinical trials, covering the complete supply chain from blinding and packaging through to global distribution and consulting, as well as the interactive technology and service solutions to increase the quality and efficiency of the clinical trial process​," she added.

Additionally, Almac's diagnostics business is providing personalized medicine services, and Christopher explained the investment will ensure space to handle larger order requirements, more staff to meet targets and deadlines, as well as an overall larger US footprint.

The next steps will be on-boarding new staff and acquiring the relevant new equipment.

Related news

Show more

Related products

show more

What do big pharma companies spend on R&D?

What do big pharma companies spend on R&D?

Zymewire | 15-Aug-2019 | Technical / White Paper

The free Big Pharma R&D Spend report examines the financial performance and research & development investments of the top 25 pharmaceutical companies...

Import Risks & Clinical Supply Depots

Import Risks & Clinical Supply Depots

Catalent Pharma Solutions | 07-Nov-2018 | Case Study

A sponsor running a clinical trial in Israel arranged to ship their clinical trial product from Europe to a depot in Israel. With the protocol based in...

Related suppliers

Follow us

Products

View more

Webinars